Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Home Biosciences is a European venture builder dedicated to biotech.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Medical documentation, Point-of-care notifications, Structured data, Open ecosystem
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Bambusa Therapeutics operates as biotechnology company.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.
Redmile Group has invested in 104 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Redmile Group's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, Kymera Therapeutics received $602.0M in a Post-IPO Equity round. Redmile Group's total known invested capital is $12.5B.
Redmile Group's average investment size is $136.1M across its portfolio of 104 companies.
Recent Redmile Group portfolio additions include Kymera Therapeutics, Home Biosciences, Escient Pharmaceuticals, Replimune Group, Invivyd. These companies were founded in 2020 or later.